Lung neoplasm malignant – Treatment

Go back

Lung cancer treatment aims to control disease progression, reduce symptoms, and improve the quality of life for patients. The approach depends heavily on the stage of disease at diagnosis, the specific type of lung cancer, and the overall health of the individual. Beyond established therapies approved by medical authorities, ongoing clinical research continues to explore new treatment possibilities that may offer additional hope to patients.

Understanding Your Treatment Path

When someone is diagnosed with malignant lung cancer, the immediate concern turns to what can be done. Treatment decisions are never simple or one-size-fits-all. They depend on several factors that doctors carefully weigh together with their patients. The type of lung cancer matters greatly because non-small cell lung cancer, which accounts for about 80 to 85 out of 100 cases, behaves differently than small cell lung cancer, which tends to grow and spread more quickly.[1][3]

The stage of cancer at diagnosis is equally important. Early-stage cancers that have not spread beyond the lung offer more treatment options and generally better outcomes. Advanced stages, where cancer has moved to lymph nodes or distant organs, require different strategies. Doctors also consider the patient’s overall health status, existing lung conditions, and ability to tolerate various treatments.[6]

Treatment for lung cancer is not just about attacking the disease. It’s also about managing symptoms, preserving breathing function, maintaining energy levels, and supporting the patient’s emotional well-being throughout the journey. Some treatments aim to cure the cancer entirely, while others focus on slowing its growth or relieving symptoms when a cure is not possible.[1]

⚠️ Important
Modern lung cancer treatment has evolved significantly in recent years. Advances in targeted therapies and immunotherapy have contributed to a significant decline in lung cancer deaths. However, the success of treatment depends greatly on early detection and the specific characteristics of each person’s cancer. Screening is now recommended for people at high risk to catch the disease when treatment options are most effective.

Standard Treatment Approaches

Established lung cancer treatments have been refined over decades and are supported by extensive clinical evidence. These therapies form the backbone of care and are recommended by medical societies worldwide.

Surgery

Surgical removal of cancerous tissue is often the first option when lung cancer is detected early and has not spread beyond the lung. During surgery, doctors may remove a portion of the lung, an entire lobe, or in some cases, the entire lung depending on the size and location of the tumor. This approach works best for patients whose cancer is confined to a small area and who are healthy enough to tolerate the procedure.[1][9]

Surgery is most commonly used for non-small cell lung cancer. The goal is to remove all visible cancer along with a margin of healthy tissue around it. Recovery from lung surgery takes time, and patients may experience breathlessness, fatigue, and pain in the weeks following the procedure. Physical rehabilitation and breathing exercises often help patients regain function.[6]

Chemotherapy

Chemotherapy uses powerful drugs to kill rapidly dividing cancer cells throughout the body. These medicines can be given as pills to swallow or as infusions directly into the veins. Chemotherapy is often used when cancer has spread beyond the lung or when doctors want to shrink a tumor before surgery or destroy any remaining cancer cells after surgery.[1][9]

The drugs work by targeting cells that divide quickly, which includes cancer cells but unfortunately also affects some healthy cells like those in the hair follicles, digestive tract, and bone marrow. This is why chemotherapy can cause side effects such as hair loss, nausea, vomiting, fatigue, increased risk of infection, and changes in appetite. Not everyone experiences all these side effects, and doctors can often prescribe supportive medications to manage them.[1]

Chemotherapy treatment for lung cancer typically involves multiple cycles over several months. Each cycle consists of treatment days followed by rest days to allow the body to recover. The specific drugs used and the duration of treatment depend on the type and stage of lung cancer.[9]

Radiation Therapy

Radiation therapy uses high-energy rays, similar to X-rays but much more powerful, to destroy cancer cells. The radiation is carefully aimed at the tumor to minimize damage to surrounding healthy tissue. This treatment is often used when surgery is not possible due to the tumor’s location or the patient’s overall health condition.[1][9]

Radiation can be used alone or combined with chemotherapy. For small cell lung cancer, which tends to spread quickly, radiation and chemotherapy together are usually the primary treatment approach. Radiation therapy is also helpful for relieving symptoms in advanced cancer, such as pain from tumors pressing on nerves or bones.[9]

Side effects from radiation depend on the area being treated but may include fatigue, skin changes in the treatment area, sore throat, difficulty swallowing, and shortness of breath. These effects typically develop gradually during treatment and may persist for some time afterward.[1]

Immunotherapy

Immunotherapy represents a newer approach that harnesses the body’s own immune system to fight cancer. Cancer cells often find ways to hide from immune cells that would normally attack them. Immunotherapy drugs help remove these disguises, allowing the immune system to recognize and destroy cancer cells.[1]

These treatments have shown promising results for some patients with non-small cell lung cancer, particularly those whose tumors express certain proteins. Immunotherapy may be used alone or combined with chemotherapy depending on the specific situation. Unlike chemotherapy, immunotherapy side effects relate to an overactive immune response and may include fatigue, skin rash, diarrhea, and inflammation in various organs.[1]

Targeted Therapy

Targeted therapies are drugs designed to attack specific changes or mutations in cancer cells. Before starting targeted therapy, doctors perform special tests on the tumor to look for specific genetic changes. If certain mutations are found, targeted drugs that specifically block the signals those mutations create can be very effective.[1][6]

These drugs work differently from chemotherapy because they target only cells with specific genetic changes, often sparing more healthy cells. This can result in fewer side effects, though targeted therapies still cause problems in some patients. Common side effects include diarrhea, skin problems, changes in hair or nails, high blood pressure, and blood clotting issues. Targeted therapies are typically given as pills taken daily.[6]

Treatment Being Tested in Clinical Trials

While standard treatments have helped many people with lung cancer, researchers continue to search for better options. Clinical trials are carefully designed studies that test new treatments or new combinations of existing treatments to see if they are safe and effective.

Understanding Clinical Trial Phases

Clinical trials progress through several phases, each designed to answer specific questions. Phase I trials focus mainly on safety, testing a new treatment in a small group of people to find the right dose and identify side effects. Phase II trials involve more participants and assess whether the treatment actually works against the cancer while continuing to monitor safety. Phase III trials are large studies that compare the new treatment to current standard treatments to determine if the new option is better, as good as, or not as effective as what is already available.[9]

Innovative Molecules and Approaches

Researchers are exploring many different strategies to fight lung cancer more effectively. Some trials investigate new targeted drugs that attack different genetic mutations found in lung cancer cells. As scientists discover more about the genetic changes that drive different lung cancers, they can design drugs to specifically block those changes.[10]

Other studies focus on new immunotherapy approaches or combinations of immunotherapy with other treatments. Scientists are testing whether combining immunotherapy drugs with chemotherapy, radiation, or targeted therapy produces better results than any treatment alone. Some trials examine whether giving immunotherapy earlier in the disease course, even before surgery, can improve outcomes.[10]

Gene therapy represents another area of investigation. These experimental treatments attempt to introduce healthy genes into cancer cells or modify genes to make cancer cells more vulnerable to treatment or to the immune system. While still largely experimental, gene therapy holds promise for future lung cancer treatment.

Researchers are also developing new drugs that target specific pathways cancer cells use to grow and spread. These might include drugs that block blood vessel formation around tumors, preventing the cancer from getting the nutrients it needs, or drugs that interfere with specific signals cancer cells use to divide and multiply.

Participating in Clinical Trials

Clinical trials are available in many locations including the United States, Europe, and other regions worldwide. Each trial has specific requirements about who can participate, based on factors like cancer type and stage, previous treatments, and overall health status. Patients interested in clinical trials should discuss this option with their doctor, who can help determine if any appropriate trials are available and whether participation might be beneficial.[9]

It’s important to understand that participating in a clinical trial means receiving treatment that is still being studied. While some patients in trials receive promising new therapies, the effectiveness and full range of side effects may not yet be fully understood. However, for some patients, especially those whose cancer has not responded to standard treatments, clinical trials may offer access to potentially helpful new options.[9]

⚠️ Important
Before starting any treatment, including participation in a clinical trial, patients should have detailed discussions with their healthcare team. Understanding the potential benefits, risks, and alternatives helps ensure that treatment decisions align with personal values and goals. Getting a second opinion from another cancer specialist is also a reasonable step that many patients take.

Most common treatment methods

  • Surgery
    • Surgical removal of cancerous tissue is used when lung cancer is detected early and confined to the lung
    • May involve removing a portion of lung, an entire lobe, or the entire lung depending on tumor size and location
    • Most commonly used for non-small cell lung cancer in patients healthy enough to tolerate the procedure
  • Chemotherapy
    • Uses powerful drugs given as pills or intravenous infusions to kill rapidly dividing cancer cells throughout the body
    • Often used when cancer has spread beyond the lung or to shrink tumors before surgery
    • Typical treatment involves multiple cycles over several months
    • Can cause side effects including hair loss, nausea, fatigue, and increased infection risk
  • Radiation therapy
    • Uses high-energy rays to destroy cancer cells while minimizing damage to healthy tissue
    • Often used when surgery is not possible or combined with chemotherapy
    • Can relieve symptoms in advanced cancer such as pain from tumors
    • For small cell lung cancer, usually combined with chemotherapy as primary treatment
  • Immunotherapy
    • Harnesses the body’s immune system to recognize and attack cancer cells
    • Removes disguises that cancer cells use to hide from immune cells
    • Shows promising results for some patients with non-small cell lung cancer
    • May be used alone or combined with chemotherapy
  • Targeted therapy
    • Drugs designed to attack specific genetic mutations in cancer cells
    • Requires special testing of tumor to identify specific genetic changes
    • Typically given as daily pills
    • Often spares more healthy cells compared to chemotherapy, resulting in different side effects

Ongoing Clinical Trials on Lung neoplasm malignant

  • Study of Sacituzumab Govitecan and Bevacizumab for Treating Brain Metastases in Patients with Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Safety of Lanreotide and Metformin for Patients with Advanced Gastrointestinal or Lung Carcinoids

    Recruiting

    2 1 1 1
    Italy
  • Study of osimertinib and febuxostat to improve drug delivery in patients with EGFR-mutated non-small cell lung cancer without brain metastases

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Evaluation of Lung Function Using Xenon Gas with CT Imaging in Lung and Breast Cancer Patients Receiving Radiotherapy

    Not yet recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium
  • Evaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Greece Hungary Italy Poland Spain
  • Study of Rilvegostomig (AZD2936) for Adults with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Denmark France The Netherlands Spain

References

https://my.clevelandclinic.org/health/diseases/4375-lung-cancer

https://www.mayoclinic.org/diseases-conditions/lung-cancer/symptoms-causes/syc-20374620

https://cancer.ca/en/cancer-information/cancer-types/lung/what-is-lung-cancer/cancerous-tumours

https://www.ncbi.nlm.nih.gov/books/NBK482357/

https://www.cdc.gov/lung-cancer/about/index.html

https://www.nhs.uk/conditions/lung-cancer/

https://www.mayoclinic.org/diseases-conditions/lung-cancer/diagnosis-treatment/drc-20374627

https://my.clevelandclinic.org/health/diseases/4375-lung-cancer

https://www.cdc.gov/lung-cancer/treatment/index.html

https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq

https://www.mdanderson.org/cancer-types/lung-cancer/lung-cancer-treatment.html

https://www.aafp.org/pubs/afp/issues/2022/0500/p487.html

https://www.ncbi.nlm.nih.gov/books/NBK482357/

https://www.lungevity.org/patients-care-partners/navigating-your-diagnosis/treatment-options-for-lung-cancer

https://www.lung.org/lung-health-diseases/lung-disease-lookup/lung-cancer/family-and-friends/taking-care-of-yourself/self-care

https://www.lungevity.org/blogs/10-tips-for-lung-cancer-caregiving

https://www.nhs.uk/conditions/lung-cancer/living-with/

https://www.lungcancerresearchfoundation.org/for-patients/print-and-digital-resources/living-with-lung-cancer/

https://www.cancercare.org/publications/151-coping_with_lung_cancer

https://www.cancer.org/cancer/types/lung-cancer/after-treatment/follow-up.html

https://www.cancerresearchuk.org/about-cancer/lung-cancer/living-with/coping

https://www.cdc.gov/lung-cancer/prevention/index.html

https://www.healthline.com/health/lung-cancer/taking-care-of-yourself-during-treatment

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What determines which lung cancer treatment I will receive?

Treatment decisions depend on several key factors: the type of lung cancer (non-small cell or small cell), the stage of disease (whether it has spread), your overall health and ability to tolerate treatment, and in some cases, specific genetic mutations found in your tumor. Your doctor will discuss these factors with you to determine the most appropriate treatment approach.

Can lung cancer be cured?

Early-stage lung cancer that has not spread beyond the lung offers the best chance for cure, particularly with surgical removal. However, when cancer has spread to lymph nodes or distant organs, treatment typically focuses on controlling disease progression, managing symptoms, and maintaining quality of life rather than achieving a complete cure. Advances in treatment have improved outcomes for many patients.

How long does lung cancer treatment last?

Treatment duration varies greatly depending on the approach. Surgery is a one-time procedure followed by recovery, though additional treatments may follow. Chemotherapy typically involves multiple cycles over several months. Radiation therapy may last several weeks with daily treatments. Targeted therapy and immunotherapy may continue for months or even years as long as they remain effective and side effects are manageable.

What are clinical trials and should I consider participating?

Clinical trials are research studies that test new treatments or new combinations of existing treatments. They progress through phases to evaluate safety and effectiveness. Participating in a clinical trial may provide access to promising new therapies, though the full benefits and risks may not yet be known. Discuss this option with your doctor to determine if any appropriate trials are available and whether participation might be beneficial for your situation.

🎯 Key takeaways

  • Lung cancer treatment depends heavily on disease type, stage at diagnosis, and patient health status, making personalized treatment planning essential.
  • Non-small cell lung cancer and small cell lung cancer behave differently and require different treatment strategies.
  • Standard treatments include surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy, often used in combination.
  • Recent advances in targeted therapies and immunotherapy have contributed to a significant decline in lung cancer deaths.
  • Targeted therapy requires special genetic testing of the tumor to identify specific mutations that drugs can attack.
  • Clinical trials offer access to promising new treatments and represent an important option for some patients, particularly when standard treatments have not been effective.
  • Managing side effects and maintaining quality of life are important goals alongside controlling the cancer itself.